These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 4382374)

  • 1. Reversal of alpha-methyltyrosine-induced behavioural depression with dihydroxyphenylalanine and amphetamine.
    Moore KE; Rech RH
    J Pharm Pharmacol; 1967 Jun; 19(6):405-7. PubMed ID: 4382374
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiamphetamine effects following inhibition of tyrosine hydroxylase.
    Weissman A; Koe BK; Tenen SS
    J Pharmacol Exp Ther; 1966 Mar; 151(3):339-52. PubMed ID: 5938473
    [No Abstract]   [Full Text] [Related]  

  • 3. Alterations in behavior and brain catecholamine levels in rats treated with alpha-methyltyrosine.
    Rech RH; Borys HK; Moore KE
    J Pharmacol Exp Ther; 1966 Sep; 153(3):412-9. PubMed ID: 5922318
    [No Abstract]   [Full Text] [Related]  

  • 4. Antagonism by monoamine oxidase inhibitors of alpha-methyltyrosine-induced catecholamine depletion and behavioral depression.
    Moore KE; Rech RH
    J Pharmacol Exp Ther; 1967 Apr; 156(1):70-5. PubMed ID: 6023602
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of catecholamines in the amphetamine excitatory response.
    Randrup A; Munkvad I
    Nature; 1966 Jul; 211(5048):540. PubMed ID: 5967502
    [No Abstract]   [Full Text] [Related]  

  • 6. Behavioral effects of L-alpha-methyltyrosine, an inhibitor of tyrosine hydroxylase.
    Weissman A; Koe BK
    Life Sci; 1965 May; 4(10):1037-48. PubMed ID: 5838507
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of L-DOPA on conditioned avoidance responding after behavioural suppression by alpha-methyltyrosine or reserpine in mice.
    Ahlenius S
    Neuropharmacology; 1974 Aug; 13(8):729-39. PubMed ID: 4444759
    [No Abstract]   [Full Text] [Related]  

  • 8. Catecholamines, drugs, and behavior: mutual interactions.
    Seiden LS; Campbell AB
    Adv Biochem Psychopharmacol; 1974; 12(0):325-38. PubMed ID: 4418348
    [No Abstract]   [Full Text] [Related]  

  • 9. Central effects of an inhibitor of tyrosine hydroxylation.
    Corrodi H; Hanson LC
    Psychopharmacologia; 1966; 10(2):116-25. PubMed ID: 5982985
    [No Abstract]   [Full Text] [Related]  

  • 10. The disruption of conditioned avoidance response following selective depletion of brain catechol amines.
    Hanson LC
    Psychopharmacologia; 1965 Jul; 8(2):100-10. PubMed ID: 5853733
    [No Abstract]   [Full Text] [Related]  

  • 11. Refillment of the catecholamine stores with 3,4-dihydroxyphenylalanine after depletion induced by inhibition of tyrosine-hydroxylase.
    Corrodi H; Fuxe K; Hökfelt T
    Life Sci; 1966 Apr; 5(7):605-11. PubMed ID: 5960198
    [No Abstract]   [Full Text] [Related]  

  • 12. Potentiation of the haloperidol-induced blockade of a conditioned avoidance response by alpha-methyltyrosine.
    Monti JM; Ruiz M
    Eur J Pharmacol; 1973 Oct; 24(1):25-8. PubMed ID: 4756166
    [No Abstract]   [Full Text] [Related]  

  • 13. Antihypertensive effects of alpha-methylated catecholamine analogues in the rat.
    Brunner H; Hedwall PR; Maître L; Meier M
    Br J Pharmacol Chemother; 1967 May; 30(1):108-22. PubMed ID: 6039967
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute effects of alpha-methyltyrosine on brain catecholamine levels and on spontaneous and amphetamine-stimulated motor activity in mice.
    Dominic JA; Moore KE
    Arch Int Pharmacodyn Ther; 1969 Mar; 178(1):166-76. PubMed ID: 5353469
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of brain amines in learning associated with "amphetamine-state".
    Roffman M; Lal H
    Psychopharmacologia; 1972; 25(3):195-204. PubMed ID: 4402958
    [No Abstract]   [Full Text] [Related]  

  • 16. Passive avoidance performance correlates with catecholamine turnover in discrete limbic brain regions.
    Kovács GL; Versteeg DH; de Kloet ER; Bohus B
    Life Sci; 1981 Mar; 28(10):1109-16. PubMed ID: 6112649
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of alpha-methyltyrosine on brain catecholamines and conditioned behavior in guinea pigs.
    Moore KE
    Life Sci; 1966 Jan; 5(1):55-65. PubMed ID: 5933656
    [No Abstract]   [Full Text] [Related]  

  • 18. The effects of DL- -methyltyrosine and L-DOPA on the hyperthermic and behavioral actions of LSD in rabbits.
    Horita A; Hamilton AE
    Neuropharmacology; 1973 May; 12(5):471-6. PubMed ID: 4708475
    [No Abstract]   [Full Text] [Related]  

  • 19. [Significance of catecholamines for the manifestation of morphine withdrawal in the rat].
    Bläsig J; Papeschi R; Herz A
    Arzneimittelforschung; 1974 Jul; 24(7):1015-6. PubMed ID: 4408108
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanism of the gamma-hydroxybutyrate-induced increase in brain dopamine and its relationship to "sleep".
    Roth RH; Suhr Y
    Biochem Pharmacol; 1970 Dec; 19(12):3001-12. PubMed ID: 5513037
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.